Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Published 28/03/2024, 12:21
© Reuters.  Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results.

RH posted weaker-than-expected results for its fourth quarter, but issued upbeat forecast. The company said it sees full-year 2024 demand growth of 12% to 14% and revenue growth of 8% to 10% on a year-over-year basis, according to data from Benzinga Pro.

RH shares jumped 9.4% to $324.99 in pre-market trading

Here are some other stocks moving in pre-market trading.

Gainers

  • Avalo Therapeutics, Inc. (NASDAQ: AVTX) rose 256.6% to $16.94 in pre-market trading after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio.
  • Binah Capital Group, Inc. (NASDAQ: BCG) gained 149% to $23.65 in pre-market trading after dipping more than 20% on Wednesday.
  • Kidpik Corp. (NASDAQ: PIK) gained 49.5% to $4.89 in pre-market trading.
  • Kidpik recently regained compliance with the Nasdaq minimum bid price requirement.
  • Kintara Therapeutics, Inc. (NASDAQ: KTRA) shares rose 36.3% to $0.1220 in pre-market trading. Kintara Therapeutics announced expansion of REM-001 clinical study to include patients on pembrolizumab.
  • Cazoo Group Ltd (NASDAQ: CZOO) gained 32.2% to $16.60 in pre-market trading after jumping over 100% on Wednesday.
  • Akebia Therapeutics, Inc. (NASDAQ: AKBA) shares rose 25% to $2.80 in pre-market trading. Akebia's received the FDA approval of Vafseo® tablets for dialysis-related anemia treatment.
  • Longeveron Inc. (NASDAQ: LGVN) gained 17% to $3.66 in pre-market trading. Longeveron’s board recently approved a 1-for-10 reverse split of Class A common stock.
  • 22nd Century Group, Inc. (NASDAQ: XXII) climbed 14.1% to $0.15 in pre-market trading. 22nd Century Group is expected to report quarterly earnings today.
  • GigaCloud Technology Inc. (NASDAQ: GCT) shares rose 9% to $28.50 in pre-market trading. GigaCloud Technology filed annual report on Form 10-K for fiscal year 2023.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • GCT Semiconductor Holding Inc, (NYSE: GCTS) dipped 21.2% to $34.68 in pre-market trading amid volatility following the company's recently completed business combination with Concord Acquisition Corp III and NYSE debut.
  • MillerKnoll, Inc. (NASDAQ: MLKN) shares fell 17.4% to $25.19 in pre-market trading as the company reported downbeat sales for its third quarter and issued weak guidance for the fourth quarter.
  • Gamida Cell Ltd. (NASDAQ: GMDA) shares tumbled 16.6% to $0.0494 in pre-market trading. Gamida Cell shares dipped over 82% on Wednesday after the company reported fourth-quarter results and disclosed the commencement of a restructuring process.
  • urban-gro, Inc. (NASDAQ: UGRO) declined 16.3% to $1.5196 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.
  • Movella Holdings Inc. (NASDAQ: MVLA) fell 15.2% to $0.0640 pre-market trading after dipping 20% on Wednesday.
  • NuCana plc (NASDAQ: NCNA) fell 13.4% to $0.2702 in pre-market trading. NuCana announced a plan to implement 1-for-25 ADS ratio change.
  • The Chemours Company (NYSE: CC) shares dropped 10% to $26.00 in pre-market trading after the company reported fourth-quarter results. The company also disclosed material weaknesses and remediation plan .
  • Abits Group Inc. (NASDAQ: ABTS) fell 9.2% to $0.7083 in pre-market trading.
  • Hitek Global Inc. (NASDAQ: HKIT) fell 8.1% to $1.60 in pre-market trading after gaining over 22% on Wednesday.
  • SOBR Safe, Inc. (NASDAQ: SOBR) fell 8% to $0.46 pre-market trading after gaining 12% on Wednesday.

Now Read This: RH, Walgreens And 3 Stocks To Watch Heading Into Thursday

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.